Aethlon Medical, Inc (AEMD) a development stage medical device company, focuses on research and development of diagnostic and therapeutic filtration devices to improve the health of individuals afflicted with infectious diseases and cancer.

The company’s lead product, the Hemopurifier, is a platform technology that combines the scientific methods of hemodialysis and affinity chromatography as a means to augment the natural immune response of clearing infectious viruses from the blood before the occurrence of cell and organ infection. The Hemopurifier targets to inhibit disease progression of hepatitis-c virus and human immunodeficiency virus, as well as bioterror and pandemic threats.

The company was founded in 1991 and is based in San Diego, California.

Information provided by Capital IQ.

http://www.aethlonmedical.com

Track Four - 2:00 pm